akaalpharma.com
About company
Akaal Pharma is a clinical-stage drug discovery and development biopharmaceutical company focused on developing novel drugs for the treatment of autoimmune, inflammatory and immune diseases. Akaal has created a pipeline of new small molecule drugs for the treatment of atopic dermatitis, psoriasis, arthritis pain, multiple sclerosis (MS) and ulcerative colitis (UC). Akaal Pharma applies its proprietary medicinal chemistry and drug discovery platform coupled with broad and in-depth drug discovery and development expertise of our leadership team. Akaal Pharma has strong portfolio of intellectual property/patents on its internally discovered drug candidates. Several patents have been issued including in the US, Europe, Japan, China, Australia and New Zealand. The remaining patents to be issued in Canada, India and other countries are in the process.
